bioRxiv Science⌕ Search

Biology subjects

Beg, M. F.

Publications and source records attributed to Beg, M. F..

2 recordsLinked to original sources

Investigating the temporal pattern of neuroimaging-based brain age estimation as a biomarker for Alzheimer's Disease related neurodegeneration

Neuroimaging-based brain-age estimation via machine learning has emerged as an important new approach for studying brain aging. The difference between ones estimated brain age and chronological age, the brain age gap (BAG), has been proposed as an Alzheimers Disease (AD) biomarker. However, most past studies on the BAG have been cross-sectional. Identifying how an individuals BAG temporal pattern changes over time would enable improved prediction of clinical outcome based on neurophysiological changes and better understanding of AD progression. To fill this gap, our study conducted predictive modeling using large neuroimaging data with up to 8 years of follow-up to examine the temporal patterns of the BAGs trajectory and how it varies by subject-level characteristics and disease status. To the best of our knowledge, this is the first effort to take a longitudinal approach to investigate the pattern and rate of change in BAG over time in individuals who progress from mild cognitive impairment (MCI) to clinical AD. Combining multimodal imaging data in a support vector regression model to estimate brain age yielded improved performance than single modality. Multilevel modeling results showed the BAG followed a linear increasing trajectory with a significantly faster rate in individuals with MCI who progressed to AD compared to cognitively normal or MCI individuals who did not progress. The dynamic changes in the BAG during AD progression were further moderated by gender and APO{varepsilon}4 carriership. Findings demonstrate the BAG as a potential biomarker for understanding individual specific temporal patterns related to AD progression.

neuroscience↗

Multivariate association between single-nucleotide polymorphisms in Alzgene linkage regions and structural changes in the brain: discovery, refinement and validation

Both genetic variants and brain region abnormalities are recognized to play a role in cognitive decline. We explore the association between singlenucleotide polymorphisms (SNPs) in linkage regions for Alzheimers disease and rates of decline in brain structure using data from the Alzheimers Disease Neuroimaging Initiative (ADNI).\n\nIn an initial discovery stage, we assessed the presence of linear association between the minor allele counts of 75,845 SNPs in the Alzgene linkage regions and predicted rates of change in structural MRI measurements for 56 brain regions using an RV test. In a second, refinement stage, we reduced the number of SNPs using a bootstrap-enhanced sparse canonical correlation analysis (SCCA) with a fixed tuning parameter. Each SNP was assigned an importance measure proportional to the number of times it was estimated to have a nonzero coefficient in repeated re-sampling from the ADNI-1 sample. We created refined lists of SNPs based on importance probabilities greater than 50% and 90%, respectively. In a third, validation stage, we assessed the multivariate association between these refined lists of SNPs and the rates of structural change in the independent ADNI-2 study dataset.\n\nThere was strong statistical evidence for linear association between the SNPs in the Alzgene linkage regions and the 56 imaging phenotypes in both the ADNI-1 and ADNI-2 samples (p < 0.0001). The bootstrap-enhanced SCCA identified 1,694 priority SNPs with importance probabilities > 50% and 22 SNPs with importance probabilities > 90%. The 1,694 prioritized SNPs in the ADNI-1 data were associated with imaging phenotypes in the ADNI-2 data (p = 0.0021).\n\nThis manuscript presents an analysis that addresses challenges in current imaging genetics studies such as biased sampling designs and highdimensional data with low-signal. Genes corresponding to priority SNPs having the highest contribution in the validation data have previously been implicated or hypothesized to be implicated in AD, including GCLC, IDE, and STAMBP1andFAS. We hypothesize that the effect sizes of the 1,694 SNPs in the priority set are likely small, but further investigation within this set may advance understanding of the missing heritability in late-onset Alzheimers disease. Multivariate analysis; Linkage regions; Imaging genetics; Endophenotypes; Inverse probability weighting; Variable importance probabilities

neuroscience↗